Javascript must be enabled to continue!
Quantitative Assessment of Myocardial Perfusion in Physiological and Pathological Hypertrophy Using Myocardial Contrast Echocardiography
View through CrossRef
ABSTRACT
Objective
To quantitatively evaluate myocardial perfusion levels in patients with physiological and pathological myocardial hypertrophy using myocardial contrast echocardiography (MCE), and to investigate the diagnostic value of MCE parameters for differentiating between these conditions.
Methods
From June 2023 to December 2024, 25 hypertensive patients with myocardial hypertrophy (pathological hypertrophy group), 25 healthy athletes (physiological hypertrophy group), and 25 healthy controls were enrolled. All participants underwent two‐dimensional echocardiography and MCE. Myocardial perfusion parameters—peak intensity (
A
‐value), wash‐in slope (
β
‐value), and myocardial blood flow (MBF)—were quantified using a 17‐segment model. Differences in perfusion parameters were compared, and receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic efficacy.
Results
Compared with controls, the physiological hypertrophy group showed significantly increased peak intensity (
A
‐value) and MBF (
p
< 0.05), whereas the pathological hypertrophy group exhibited decreased A‐value, slope rate
(β
‐value), and MBF (
p
< 0.05). Intragroup segmental analysis revealed that in pathological hypertrophy, the basal segments had significantly lower A‐value and MBF compared to mid and apical segments (
p
< 0.05). Intermural comparison demonstrated that in both control and physiological hypertrophy groups, the free wall had lower
A
‐value and MBF than the septum (
p
< 0.05). In contrast, pathological hypertrophy showed reduced
A
‐value but increased
β
‐value in the free wall (
p
< 0.05). ROC curve analysis identified an optimal cutoff value of
A
> 8.13 dB (AUC = 0.904) for discriminating exercise‐induced physiological hypertrophy from hypertension‐induced pathological hypertrophy.
Conclusion
MCE enables quantitative assessment of myocardial perfusion in hypertrophic patients. The
A
value, reflecting microvascular density, serves as a reliable discriminator between physiological and pathological hypertrophy.
Title: Quantitative Assessment of Myocardial Perfusion in Physiological and Pathological Hypertrophy Using Myocardial Contrast Echocardiography
Description:
ABSTRACT
Objective
To quantitatively evaluate myocardial perfusion levels in patients with physiological and pathological myocardial hypertrophy using myocardial contrast echocardiography (MCE), and to investigate the diagnostic value of MCE parameters for differentiating between these conditions.
Methods
From June 2023 to December 2024, 25 hypertensive patients with myocardial hypertrophy (pathological hypertrophy group), 25 healthy athletes (physiological hypertrophy group), and 25 healthy controls were enrolled.
All participants underwent two‐dimensional echocardiography and MCE.
Myocardial perfusion parameters—peak intensity (
A
‐value), wash‐in slope (
β
‐value), and myocardial blood flow (MBF)—were quantified using a 17‐segment model.
Differences in perfusion parameters were compared, and receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic efficacy.
Results
Compared with controls, the physiological hypertrophy group showed significantly increased peak intensity (
A
‐value) and MBF (
p
< 0.
05), whereas the pathological hypertrophy group exhibited decreased A‐value, slope rate
(β
‐value), and MBF (
p
< 0.
05).
Intragroup segmental analysis revealed that in pathological hypertrophy, the basal segments had significantly lower A‐value and MBF compared to mid and apical segments (
p
< 0.
05).
Intermural comparison demonstrated that in both control and physiological hypertrophy groups, the free wall had lower
A
‐value and MBF than the septum (
p
< 0.
05).
In contrast, pathological hypertrophy showed reduced
A
‐value but increased
β
‐value in the free wall (
p
< 0.
05).
ROC curve analysis identified an optimal cutoff value of
A
> 8.
13 dB (AUC = 0.
904) for discriminating exercise‐induced physiological hypertrophy from hypertension‐induced pathological hypertrophy.
Conclusion
MCE enables quantitative assessment of myocardial perfusion in hypertrophic patients.
The
A
value, reflecting microvascular density, serves as a reliable discriminator between physiological and pathological hypertrophy.
Related Results
Virtual drug screen reveals context-dependent inhibition of cardiomyocyte hypertrophy
Virtual drug screen reveals context-dependent inhibition of cardiomyocyte hypertrophy
ABSTRACT
Background and Purpose
Pathological cardiomyocyte hypertrophy is a response to cardiac stress that typically leads to ...
Value of Visual and Quantitative Analysis of Thallium-201 Imaging in Patients with Diagnostic and Non-Diagnostic Exercise Electrocardiograms
Value of Visual and Quantitative Analysis of Thallium-201 Imaging in Patients with Diagnostic and Non-Diagnostic Exercise Electrocardiograms
Myocardial 201T1 imaging in conjunction with exercise stress testing has become an accepted technique
for evaluating patients with known or suspected coronary artery disease. Espec...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Hypertrophy Energy Balance
Hypertrophy Energy Balance
The present chapter delves into the topic of muscle hypertrophy in detail, focusing on defining what muscle hypertrophy is, the types of hypertrophy, the mechanisms, and the relati...
The value of myocardial contrast echocardiography in evaluating the relationship between myocardial perfusion and cardiac resynchronisation therapy: an animal study
The value of myocardial contrast echocardiography in evaluating the relationship between myocardial perfusion and cardiac resynchronisation therapy: an animal study
Objective
To establish an animal model of heart failure and cardiac resynchronisation therapy (CRT) after myocardial infarction. Myocardial contrast echocardiogra...
ADENO TONSILLAR DISEASE –THE CLINICAL & AUDIOLOGICAL PERSPECTIVES
ADENO TONSILLAR DISEASE –THE CLINICAL & AUDIOLOGICAL PERSPECTIVES
Aim: To study the Audiological prole of cases with Adenoid Hypertrophy, Tonsillar Hypertrophy and Adeno-tonsillar Hypertrophy
Objectives:
a. To evaluate for hearing loss in patien...
THE REASEARCH INTO THE CLINICAL CHARACTERISTICS OF PERIPARTUM CARDIOMYOPATHY
THE REASEARCH INTO THE CLINICAL CHARACTERISTICS OF PERIPARTUM CARDIOMYOPATHY
Objectives
The research is to find the related risk factors that may lead to PPCM through analysing and summarising the general clinical characteristics of PPCM p...
PS01.160: PERIOPERATIVE PERFUSION ASSESSMENT WITH QUANTITATIVE FLUORESCENCE ANGIOGRAPHY
PS01.160: PERIOPERATIVE PERFUSION ASSESSMENT WITH QUANTITATIVE FLUORESCENCE ANGIOGRAPHY
Abstract
Background
Anastomotic leakage (AL) occurs relatively frequent in oncologic esophageal surgery and is associated with i...

